{Reference Type}: Journal Article
{Title}: A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.
{Author}: Padayachee S;Moodley J;Naicker T;
{Journal}: Curr Hypertens Rep
{Volume}: 21
{Issue}: 9
{Year}: 07 2019 24
{Factor}: 4.592
{DOI}: 10.1007/s11906-019-0970-7
{Abstract}: This review provides a comprehensive insight into the angiogenic profile of hypertensive and normotensive pregnancies compromised by HIV infection. Furthermore, we evaluate the economic implementation of the sFlt-1/PlGF ratio and review the reports on therapeutic apheresis in limiting sFlt-1 production.<BR>In preeclampsia, an increased expression of sFlt-1 triggers angiogenic imbalance. Women of African ancestry have high levels of angiogenic factors than other racial groups. The sFlt-1/PlGF ratio shows promise in the early assessment of preeclampsia, while sFlt-1 apheresis restores angiogenic imbalance. Studies suggest antiretroviral therapy does not impact the angiogenic shift in preeclampsia development. The angiogenic profile in pregnant women of different races influences preeclampsia development. Despite the opposing immune response in HIV infection and preeclampsia, the HIV tat protein strongly mimics vascular endothelial growth factor (VEGF); hence, it is plausible to assume that HIV infection may ameliorate the angiogenic imbalance in preeclampsia.